Skip to main content

The Federal Drug Administration has cleared wireless integration between Johnson & Johnson’s OneTouch Verio Flex monitoring system and WellDoc’s BlueStar diabetes management platform via Bluetooth capability. BlueStar will use the data to provide a personalized and real-time feedback to consumers and offer virtual coaching for a complete treatment plan. BlueStar will also let physicians make treatment management decisions based on that real-time data. Consumers can access this management solution through a mobile app or a website.

The BlueStar app requires a prescription to download, but is otherwise free to consumers.

Johnson & Johnson has brought innovative, collaborative health and well-being products and solutions to the public for more than 130 years.

Welldoc is a company committed to providing innovative mobile technology solutions that integrate with the health care system to help consumers manage type 2 diabetes on a day-to-day basis.

This was reported by FierceBiotech on December 14, 2016.

Contact Information: Johnson & Johnson, One Johnson & Johnson Plaza, New Brunswick, NJ 08933; 443-692-3100; Email: mediarelations@its.jnj.com; Website: www.jnj.com

Contact Information: WellDoc, 10221 Wincopin Circle, Suite 150, Columbia, MD 21044; 732-524-0400; Email: info@welldoc.com; Website: www.welldoc.com


Tagged As:

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!

Close

Support Request

Need help now?

Call our toll-free phone number 877-350-6463